Arhaus, Inc.
ARHSConsumer CyclicalNASDAQSpecialty Retail
Scan Results
Daily timeframePart of the consumer cyclical sector, Arhaus, Inc. (ARHS) is listed under Specialty Retail. Valued at $1.63B, ARHS is a small-cap name in its sector. The company offers bedroom, dining room, and living room, as well as home office furnishings, including sofas, dining tables and chairs, accent chairs, console and coffee tables, beds, headboards, dressers, desks, bookcases, modular storage, and other items; and outdoor products, such as outdoor dining tables, chairs, chaises and other furniture, lighting, textiles, décor, umbrellas, and fire pits.
Market Cap
$1.63B
Beta
2.31
P/E (TTM)
21.75
P/E (Fwd)
20.01
EPS (TTM)
$0.53
EPS (Fwd)
$0.58
ROE
17.3%
ROA
3.1%
Cash
$230.4M
Total Debt
$609.2M
Free CF
$79.3M
52W Change
10.9%
Annual Financials
Cash vs Debt
Where ARHS stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, ARHS finished 30.15% above its 150-day moving average ($7.86) and 25.06% above its 200-day moving average ($8.18). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is ARHS overbought or oversold?
At the October 20, 2026 close, ARHS's RSI(14) was 61.9, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
On the balance sheet, ARHS has $230.4M in cash with $609.2M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $79.3M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 17.3% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.1% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $1.23B to $1.38B.
Arhaus, Inc.'s elevated beta suggests the stock experiences more pronounced price movements than the overall market, which increases both upside potential and downside risk. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ARHS.